Cargando…

FKBP5 associated CD8 T cell infiltration is a novel prognostic biomarker in luminal B breast cancer

OBJECTIVE: To investigate the relationship between FKBP prolyl isomerase 5 (FKBP5) gene expression and CD8 T cells in tumour progression and immunology of the luminal B subtype of breast cancer (LBBC) using bioinformatics analyses. METHODS: The Gene Expression Profiling Interactive Analysis 2, Human...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Fei, Lu, Genlin, Zang, Jie, Hao, Dingji, Xu, Wangjue, Chen, Jida, Ding, Qiong, Xiong, Hanchu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664447/
https://www.ncbi.nlm.nih.gov/pubmed/37987640
http://dx.doi.org/10.1177/03000605231211771
_version_ 1785148738561376256
author Tong, Fei
Lu, Genlin
Zang, Jie
Hao, Dingji
Xu, Wangjue
Chen, Jida
Ding, Qiong
Xiong, Hanchu
author_facet Tong, Fei
Lu, Genlin
Zang, Jie
Hao, Dingji
Xu, Wangjue
Chen, Jida
Ding, Qiong
Xiong, Hanchu
author_sort Tong, Fei
collection PubMed
description OBJECTIVE: To investigate the relationship between FKBP prolyl isomerase 5 (FKBP5) gene expression and CD8 T cells in tumour progression and immunology of the luminal B subtype of breast cancer (LBBC) using bioinformatics analyses. METHODS: The Gene Expression Profiling Interactive Analysis 2, Human Protein Atlas and breast cancer gene-expression miner v4.5 databases were used for data mining and analysing FKBP5, its co-expressed genes and CD8 T cell-related markers. The Tumor IMmune Estimation Resource 2.0 database was used for analysing the correlation and prognosis of FKBP5 and CD8 T cell infiltration level in LBBC. RESULTS: Upregulated FKBP5 expression was correlated with improved survival in LBBC. Upregulated FKBP5-related CD8 T cell markers were also demonstrated to be significantly correlated with better survival in LBBC and might play a role in the biological activity of FKBP5. CONCLUSION: These findings suggest that FKBP5 and its associated CD8 T cell infiltration are potential benign prognostic indicators for LBBC.
format Online
Article
Text
id pubmed-10664447
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-106644472023-11-21 FKBP5 associated CD8 T cell infiltration is a novel prognostic biomarker in luminal B breast cancer Tong, Fei Lu, Genlin Zang, Jie Hao, Dingji Xu, Wangjue Chen, Jida Ding, Qiong Xiong, Hanchu J Int Med Res Pre-Clinical Research Report OBJECTIVE: To investigate the relationship between FKBP prolyl isomerase 5 (FKBP5) gene expression and CD8 T cells in tumour progression and immunology of the luminal B subtype of breast cancer (LBBC) using bioinformatics analyses. METHODS: The Gene Expression Profiling Interactive Analysis 2, Human Protein Atlas and breast cancer gene-expression miner v4.5 databases were used for data mining and analysing FKBP5, its co-expressed genes and CD8 T cell-related markers. The Tumor IMmune Estimation Resource 2.0 database was used for analysing the correlation and prognosis of FKBP5 and CD8 T cell infiltration level in LBBC. RESULTS: Upregulated FKBP5 expression was correlated with improved survival in LBBC. Upregulated FKBP5-related CD8 T cell markers were also demonstrated to be significantly correlated with better survival in LBBC and might play a role in the biological activity of FKBP5. CONCLUSION: These findings suggest that FKBP5 and its associated CD8 T cell infiltration are potential benign prognostic indicators for LBBC. SAGE Publications 2023-11-21 /pmc/articles/PMC10664447/ /pubmed/37987640 http://dx.doi.org/10.1177/03000605231211771 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Pre-Clinical Research Report
Tong, Fei
Lu, Genlin
Zang, Jie
Hao, Dingji
Xu, Wangjue
Chen, Jida
Ding, Qiong
Xiong, Hanchu
FKBP5 associated CD8 T cell infiltration is a novel prognostic biomarker in luminal B breast cancer
title FKBP5 associated CD8 T cell infiltration is a novel prognostic biomarker in luminal B breast cancer
title_full FKBP5 associated CD8 T cell infiltration is a novel prognostic biomarker in luminal B breast cancer
title_fullStr FKBP5 associated CD8 T cell infiltration is a novel prognostic biomarker in luminal B breast cancer
title_full_unstemmed FKBP5 associated CD8 T cell infiltration is a novel prognostic biomarker in luminal B breast cancer
title_short FKBP5 associated CD8 T cell infiltration is a novel prognostic biomarker in luminal B breast cancer
title_sort fkbp5 associated cd8 t cell infiltration is a novel prognostic biomarker in luminal b breast cancer
topic Pre-Clinical Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664447/
https://www.ncbi.nlm.nih.gov/pubmed/37987640
http://dx.doi.org/10.1177/03000605231211771
work_keys_str_mv AT tongfei fkbp5associatedcd8tcellinfiltrationisanovelprognosticbiomarkerinluminalbbreastcancer
AT lugenlin fkbp5associatedcd8tcellinfiltrationisanovelprognosticbiomarkerinluminalbbreastcancer
AT zangjie fkbp5associatedcd8tcellinfiltrationisanovelprognosticbiomarkerinluminalbbreastcancer
AT haodingji fkbp5associatedcd8tcellinfiltrationisanovelprognosticbiomarkerinluminalbbreastcancer
AT xuwangjue fkbp5associatedcd8tcellinfiltrationisanovelprognosticbiomarkerinluminalbbreastcancer
AT chenjida fkbp5associatedcd8tcellinfiltrationisanovelprognosticbiomarkerinluminalbbreastcancer
AT dingqiong fkbp5associatedcd8tcellinfiltrationisanovelprognosticbiomarkerinluminalbbreastcancer
AT xionghanchu fkbp5associatedcd8tcellinfiltrationisanovelprognosticbiomarkerinluminalbbreastcancer